Journal of Pregnancy / 2014 / Article / Tab 2

Clinical Study

Revisiting the Role of First Trimester Homocysteine as an Index of Maternal and Fetal Outcome

Table 2

Homocysteine levels with reference to outcome of past pregnancies.

  No prior first trimester loss
( = 64)
One prior first trimester loss
( = 27)
Two prior first trimester losses
( = 9)
valueTest used

Serum homocysteine ( mol/L)12.80 ± 6.58 15.25 ± 7.58 17.08 ± 5.800.1687One way ANOVA

  No prior second trimester loss
( = 88)
One prior second trimester loss
( = 9)
Two prior second trimester losses
( = 3)
    

Serum homocysteine ( mol/L)13.59 ± 7.0216.72 ± 2.89 6.52 ± 0.500.0307 * Kruskal-Wallis test

  No intrauterine fetal death in the third trimester
( = 91)
One previous intrauterine fetal death in the third trimester
( = 9)
    

Serum homocysteine ( mol/L)13.16 ± 5.7523.79 ± 9.21 <0.0001 ** Unpaired -test

  No prior pregnancy loss (any trimester)
( = 52)
One prior pregnancy loss
( = 25)
Two prior pregnancy losses
( = 19)
Three prior pregnancy losses
( = 4)
    

Serum homocysteine ( mol/L)11.08 ± 4.1813.46 ± 7.1519.23 ± 6.6517.80 ± 6.410.0002 ** Kruskal-Wallis test

significant.
** highly significant.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.